RxDoctor Payments Data

Keri Moon, PA

Physician Assistant · Temple, TXNPI 1982079315

Payments from drug & device makers

$388in general payments, 2019–2025

Across 22 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$70
  • Regeneron Healthcare Solutions, Inc.$60
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • CSL Behring$43
  • GSK$40
  • Grifols USA, LLC$36
  • plus $89 from 4 others

What the payments were for

  • Food & beverage$388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388 in reported general payments places this provider in the 45th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$35,946
Medicare patients
297
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$78,233
TrulicityDulaglutide20$36,699
JardianceEmpagliflozin23$34,014
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$31,530
EliquisApixaban18$23,961
FarxigaDapagliflozin Propanediol17$23,843
MounjaroTirzepatide15$17,995
SymbicortBudesonide/Formoterol Fumarate17$4,460
Atorvastatin Calcium99$1,747
Losartan Potassium89$1,680
Lisinopril107$1,428
Fluticasone Propionate72$1,349
Gabapentin69$1,338
Albuterol Sulfate HfaAlbuterol Sulfate29$1,332
Famotidine52$1,329

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$20$34,01423 claims
GSKTrelegy Ellipta$40$31,53029 claims
AstraZenecaFarxiga, Symbicort$70$28,30234 claims
PfizerEliquis$28$23,96118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Temple

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →